01
Individual material
Semaglutide
30 mg / vial
Availability unavailable$100.00 / vialView material
Research peptides
Browse ivaldi research materials by type. Each listing is for laboratory research only — open a material for vial contents, documentation, and ordering.
18 of 18 materials
02
Individual material
Tirzepatide
40 mg / vial
Availability unavailable$120.00 / vialView material
03
Individual material
BPC-157
10 mg / vial
Availability unavailable$60.00 / vialView material
04
Proposed blend
CJC-1295 / Ipamorelin
5 mg / 5 mg / vial
Availability unavailable$60.00 / vialView material
05
Individual material
TB-500
10 mg / vial
Availability unavailable$50.00 / vialView material
06
Individual material
Retatrutide
60 mg / vial
Availability unavailable$300.00 / vialView material
07
Copper-peptide complex
GHK-Cu
100 mg / vial
Availability unavailable$60.00 / vialView material
08
Individual material
Sermorelin
10 mg / vial
Availability unavailable$60.00 / vialView material
09
Individual material
Tesamorelin
10 mg / vial
Availability unavailable$70.00 / vialView material
10
Individual material
MOTS-C
10 mg / vial
Availability unavailable$40.00 / vialView material
11
Individual material
Epithalon
10 mg / vial
Availability unavailable$30.00 / vialView material
12
Proposed blend
GLOW
50/10/10/70 mg / vial
Availability unavailable$140.00 / vialView material
13
Individual material
Glutathione
1,500 mg / vial
Availability unavailable$80.00 / vialView material
14
Individual material
HCG
10,000 IU / vial
Availability unavailable$100.00 / vialView material
15
Individual material
Ipamorelin
10 mg / vial
Availability unavailable$50.00 / vialView material
16
Individual material
NAD+
1,000 mg / vial
Availability unavailable$120.00 / vialView material
17
Individual material
PT-141
10 mg / vial
Availability unavailable$40.00 / vialView material
18
Proposed blend
TB-500 + BPC-157
10 mg / 10 mg / vial
Availability unavailable$80.00 / vialView material
About this order & vial amounts
The first ten follow a public editorial popularity list, reviewed September 12, 2026. This is a provisional browsing order, not ivaldi sales data or a measured market ranking. The remaining eight appear alphabetically because comparative demand is unverified.
Amounts below are proposed contents per vial, not administration doses. All labels are packaging renderings awaiting supplier confirmation.